[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.120.181. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Editor's Correspondence
April 12, 2010

The Pharmacist's Role in Off-label Prescribing—Reply

Author Affiliations

Author Affiliations: Clinical Center Department of Ethics, National Institutes of Health, Bethesda, Maryland.

Arch Intern Med. 2010;170(7):658. doi:10.1001/archinternmed.2010.71

In reply

We appreciate the supportive comments from Walton and colleagues. Their previous empirical work helped define the scale and scope of off-label prescribing and is an important adjunct to any conceptual framework.1 We agree with their conclusion that promotional efforts may be an additional flag for clinicians and professional societies to scrutinize the evidence underlying prescribing decisions.

First Page Preview View Large
First page PDF preview
First page PDF preview
×